FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula
,
where each radical R-R5 and Y assume values given in the description, or salts thereof, which have GPR40 receptor modulating action.
EFFECT: intensification of secretion of insulin or an agent for preventing or treating diabetes, and a pharmaceutical composition based on said compounds.
17 cl, 34 ex
Title | Year | Author | Number |
---|---|---|---|
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2671571C1 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2647592C2 |
FUNCTIONALISED DERIVATIVES OF MORPHOLINYLANTHRACYCLINE | 2015 |
|
RU2715902C2 |
BICYCLIC COMPOUNDS AS PD1/PD-L1 INTERACTION/ACTIVATION INHIBITORS | 2019 |
|
RU2777980C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
Authors
Dates
2012-03-10—Published
2007-06-26—Filed